TITLE

MARKETING PHARMACEUTICAL PRODUCTS IN THE TWENTY-FIRST CENTURY: AN ANALYSIS OF THE CONTINUED VIABILITY OF TRADITIONAL PRINCIPLES OF LAW IN THE AGE OF DIRECT-TO-CONSUMER ADVERTISING

AUTHOR(S)
Schwartz, Victor E.; Silverman, Cary; Hulka, Michael J.; Appel, Christopher E.
PUB. DATE
January 2009
SOURCE
Harvard Journal of Law & Public Policy;Winter2009, Vol. 32 Issue 1, p333
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article examines the viability of traditional principles of law amid the direct-to-consumer (DTC) advertising trend in the U.S. pharmaceutical industry. It discusses the history of the sale and marketing practices for pharmaceutical products which involves the establishment of the Food and Drug Administration (FDA) and the creation of the pre-market approval process. It is concluded that viability is retained in the traditional principles of law both as a matter of jurisprudence and sound public policy despite the emergence of the DTC trend.
ACCESSION #
37171238

 

Related Articles

  • ONE CLICK AWAY FROM UNTANGLING THE WEB: THE UNITED STATES FOOD AND DRUG ADMINISTRATION & INTERACTIVE PROMOTIONAL MEDIA. Gitterman, Abraham // Health Law & Policy;Spring2014, Vol. 8 Issue 2, p5 

    The article presents an analysis of the issues which should be considered by the U.S. Food and Drug Administration (FDA) and drug manufacturers while preparing the promotional media guidance. Topics discussed include building employee teams having individuals with regulatory, marketing and...

  • DRUGMAKERS SPAR WITH THE FDA OVER PROPOSED DTC ANIMATION STUDY. McCaffrey, Kevin // Medical Marketing & Media;Dec2016, Vol. 51 Issue 12, p16 

    The article reports that drugmakers are making a motion over the U.S. Food and Drug Administration's planned studies examining the use of animation in direct-to-consumer (DTC) advertising.

  • FDA Update.  // Pharmaceutical Representative;Jan2011, Vol. 41 Issue 1, p11 

    The article offers various updates related to the pharmaceutical industry and the U.S. Food and Drug Administration (FDA). It focuses on the close supervision of the FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) for direct-to-consumer drug advertising which presents...

  • CHRONOLOGY OF DIRECT-TO-CONSUMER ADVERTISING REGULATION IN THE UNITED STATES. Mogull, Scott A. // AMWA Journal: American Medical Writers Association Journal;2008, Vol. 23 Issue 3, p106 

    Promotion of pharmaceutical drugs to consumers, called direct-to-consumer (DTC) advertising, has increased significantly since 1997, when the US Food and Drug Administration (FDA) reevaluated its regulations of pharmaceutical manufacturers. DTC advertising has been debated in the literature,...

  • Branding Under Fire. Donahue, Maryly // Pharmaceutical Executive;Oct2008 Guide to Branding, p18 

    The article focuses on the impact of the pending legislation in both the U.S. House of Representatives and the U.S. Senate on the direct-to-consumer prescription drug advertising in the country. The legislation would authorize the U.S. Food and Drug Administration to screen all advertisements...

  • Helping patients navigate through DTC ads. Tanzi, Maria G. // Pharmacy Today;Jun2012, Vol. 18 Issue 6, p38 

    The article focuses on the direct-to-consumer (DTC) advertising of drugs in the U.S. It says that DTC ads feature celebrity spoke person as patients who are satisfied and benefited from the advertised treatment. It states that have to know the different types of ads permitted by the U.S. Food...

  • DTC industry fears FDA pre-approval. Thomaselli, Rich // Advertising Age;9/29/2003, Vol. 74 Issue 39, p63 

    The article reports that the U.S. Food and Drug Administration's (FDA) has heard more than 25 presentations from parties that have conducted research on direct-to-consumer (DTC) advertising. FDA will use the findings from the public hearings, as well as its own research, to determine new...

  • Researchers view a weaker DDMAC. J. G. D. // Medical Marketing & Media;Oct2007, Vol. 42 Issue 10, p15 

    The article reports that the oversight of advertising (ad) by the U.S. Food and Drug Administration's (FDA) Division of Drug Marketing, Advertising and Communications (DDMAC) has declined dramatically. According to a ten-year review of the direct-to-consumer (DTC) ad research lead by doctor...

  • Risks and Restrictions. Wechsler, Jill // Pharmaceutical Executive;Nov2009, Vol. 29 Issue 11, p18 

    The article focuses on the plan of U.S. Food and Drug Authority (FDA) seeking effective risk communication on food and medical products. It provides strategies for improving risk messages and safety information and safety alerts of the advertising and written information to the agency, industry,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics